Optimising kinase inhibitors
Challenges in the development of brain-penetrant kinase inhibitors
Date
08 Mar 2022Session
Optimising kinase inhibitorsPresenters
Neeltje SteeghsAuthors
N. SteeghsAuthor affiliations
- NKI-AVL - Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam/NL
Resources
Resources from the same session
The convergence of potency, selectivity and tumour biology: Inhibitors of NTRK, MET and RET
Presenter: Alexander Drilon
Session: Optimising kinase inhibitors
Resources:
Slides
Webcast
Broad spectrum and mutant-selective kinase inhibitor development for imatinib-resistant GIST
Presenter: Sebastian Bauer
Session: Optimising kinase inhibitors
Resources:
Slides
Webcast
Structural biology and precision targeting of RTK/RAS/MAPK inhibitors
Presenter: Elena Garralda
Session: Optimising kinase inhibitors
Resources:
Slides
Webcast
Live Q&A and discussion
Presenter: Elena Garralda
Session: Optimising kinase inhibitors
Resources:
Webcast